Click here to register to address the Federal Trade Commission (FTC). The FTC needs to hear from you about issues with the pharmacy benefit managers (PBMs) & their mail order pharmacies Optum RX, CVS Caremark, & Express Scripts.

Please support the FTC's investigation. 

They're accepting live, written, and pre-recorded 2-minute comments. Statements must be submitted no later than 8 p.m. ET on Tuesday, July 30, 2024. Click on the link for more information.

Per the FTC:

"Pharmacy Benefit Managers Report: Staff from the Office of Policy Planning will provide a presentation on the Interim Report on Pharmacy Benefit Managers (PBMs). This Interim Report is part of the Federal Trade Commission’s ongoing study of PBMs and explores their potential impact on access and affordability of medicines and examines how increasing vertical integration and concentration may have enabled PBMs to inflate drug costs and squeeze Main Street pharmacies."

Thank you, 

Loretta Boesing, Patient Advocate